CaptureSelect®
BAC’s CaptureSelect® products are affinity ligands created by a proprietary technology based on Camelid-derived single domain antibody fragments for the purification of biopharmaceuticals or scavenging of impurities in biopharmaceutical production processes. These products possess a combination of unique properties such as stability, affinity, and selectivity that provide competitive benefits in terms of reduced cost of purification, higher quality product, and increased flexibility in the purification process.
Products and services
 |  |  | ||
| Custom designed CaptureSelect® ligands | CaptureSelect® products for Bioprocess | CaptureSelect® products for Research | ||
| BAC works with partners to develop CaptureSelect ligands for specific biopharmaceutical affinity purification or scavenging applications. | CaptureSelect ligands are available as off-the-shelf products for large scale biopharmaceutical process applications. | BAC offers a range of ready-to-use research grade affinity matrices based on CaptureSelect technology. |
News and Events
BAC BV expands alliance with Octapharma Group for the purification of recombinant proteins More >
BAC expands collaboration with GE Healthcare with launch of KappaSelect More >
Meet BAC at the upcoming Antibody Development & Production conference (3-5 March - Carlsbad, CA - Booth #209). Click on the banner for a 25% discount on registration.
